Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Gao, Dong, Vela, Ian, Sboner, Andrea, Iaquinta, Phillip J., Karthaus, Wouter R., Gopalan, Anuradha, Dowling, Catherine, Wanjala, Jackline N. +31 more·2014·Cell

Cited by (1,000)

Items 401–500 of 1,000

  1. Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors
    Supreet Agarwal, Paul G. Hynes, Heather Sheppard, Ross G. Lake, Wassim G. Abou-Kheir, Lei Fang, Orla M. Casey, Amir H. Ameri, Philip L. Martin, Juan Juan Yin et al. · 2015 · Cell Reports
  2. The Genomics of Prostate Cancer: emerging understanding with technologic advances
    Mark A. Rubin, Francesca Demichelis · 2018 · Modern Pathology
  3. Characterization of single circulating tumor cells
    Catherine Alix‐Panabières, Klaus Pantel · 2017 · FEBS Letters
  4. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening
    Flávia Castro, Catarina Leite Pereira, Maria Helena Macedo, Andreia Almeida, Maria José Silveira, Sofia Dias, Ana Patrícia Cardoso, María José Oliveira, Bruno Filipe Carmelino Cardoso Sarmento · 2021 · Advanced Drug Delivery Reviews
  5. Organoids in high-throughput and high-content screenings
    Franziska L. Lampart, Dagmar Iber, Nikolaos Doumpas · 2023 · Frontiers in Chemical Engineering
  6. Cellular self-assembly and biomaterials-based organoid models of development and diseases
    Shivem B. Shah, Ankur K. Singh · 2017 · Acta Biomaterialia
  7. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer
    Xiaoyu Liu, Changyu Li, Junhao Li, Tianzhu Yu, Guofeng Zhou, Jiemin Cheng, Guoping Li, Yang Zhou, Wenhui Lou, Xiaolin Wang et al. · 2018 · Journal of Cancer
  8. Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
    Xiaoling Li, Yunguan Wang, Su Deng, Guanghui Zhu, Choushi Wang, Nickolas A. Johnson, Zeda Zhang, Carla R. Tirado, Yaru Xu, Lauren A. Metang et al. · 2023 · Cancer Cell
  9. Cancer organoids: A platform in basic and translational research
    Xin Ma, Qin Lin Wang, Guozheng Li, Hui Li, Shouping Xu, Da Pang · 2023 · Genes & Diseases
  10. Initiation, Expansion, and Cryopreservation of Human Primary Tissue‐Derived Normal and Diseased Organoids in Embedded Three‐Dimensional Culture
    James Clinton, Penney McWilliams‐Koeppen · 2018 · Current Protocols in Cell Biology
  11. Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole Blood
    Eva Undvall Anand, Cecilia Magnusson, Andreas Lenshof, Yvonne Ceder, Hans G. Lilja, Thomas Laurell · 2021 · Analytical Chemistry
  12. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
    Dannel Yeo, Althea Bastian, Heidi Strauss, Payal Saxena, Peter Grimison, John E.J. Rasko · 2022 · International Journal of Molecular Sciences
  13. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma
    Yuan‐Hung Wu, Yi‐Ping Hung, Nai‐Chi Chiu, Rheun‐Chuan Lee, Chung‐Pin Li, Yee Chao, Yi‐Ming Shyr, Shin‐E Wang, Shih‐Chin Chen, Sheng‐Hsuan Lin et al. · 2022 · European Journal of Cancer
  14. Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
    Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, Layal Ashi, Rawan A Rahman AlHarmi, Noora Hassani · 2024 · Translational Oncology
  15. Cancer stem cells: at the forefront of personalized medicine and immunotherapy
    Micol Eleonora Fiori, Lidia Villanova, Ruggero D. Maria · 2017 · Current Opinion in Pharmacology
  16. Kidney organoids in translational medicine: Disease modeling and regenerative medicine
    Tomoya Miyoshi, Ken Hiratsuka, Edgar Garcia Saiz, Ryuji Morizane · 2019 · Developmental Dynamics
  17. Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells
    Wujun Zhao, Yang Liu, Brittany Denise Jenkins, Rui Cheng, Bryana N. Harris, Weizhong Zhang, Jin Xie, Jonathan R. Murrow, Jamie Hodgson, Mary Egan et al. · 2019 · Lab on a Chip
  18. Organoid of ovarian cancer: genomic analysis and drug screening
    Huidong Liu, Bairong Xia, Mingzhu Jin, Ge Lou · 2020 · Clinical & Translational Oncology
  19. Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
    Xingwu Zhou, Moyuan Qu, Peyton J. Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta et al. · 2020 · Advanced Science
  20. The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
    Lauren M. Granat, Ooha Kambhampati, Stephanie Klosek, Brian Niedzwecki, Kian Parsa, Dong Zhang · 2019 · Animal Models and Experimental Medicine
  21. The functional and clinical roles of liquid biopsy in patient-derived models
    Ziqing Zhu, Erya Hu, Hong Shen, Jun Tan, Shan Zeng · 2023 · Journal of Hematology & Oncology
  22. Organoids from pituitary as a novel research model toward pituitary stem cell exploration
    Benoit Cox, Emma Laporte, Annelies Vennekens, Hiroto Kobayashi, Charlotte Nys, Indra Van Zundert, Hiroshi Uji‐i, Alizée Vercauteren Drubbel, Benjamin Beck, Heleen Roose et al. · 2018 · Journal of Endocrinology
  23. Progress in human liver organoids
    Lulu Sun, Lijian Hui · 2020 · Journal of Molecular Cell Biology
  24. Metabolic regulation of prostate cancer heterogeneity and plasticity
    Claudia Peitzsch, Ielizaveta Gorodetska, Daria Klusa, Qihui Shi, Tiago C. Alves, Klaus Pantel, Anna Dubrovska · 2020 · Seminars in Cancer Biology
  25. The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer
    Goutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani, Bastien Nguyen, Konrad Hermann Stopsack, Christoph K. Kreitzer, Sai Harisha Rajanala, Romina Ghale, Ying Zhang Mazzu, Nagavarakishore Pillarsetty et al. · 2022 · Clinical Cancer Research
  26. Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS–Titanium–Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release
    Elyahb Allie Kwizera, Wenquan Ou, So Jeong Lee, Samantha Stewart, James G. Shamul, Jiangsheng Xu, Nancy S. Tait, Katherine H. R. Tkaczuk, Xiaoming He · 2022 · ACS Nano
  27. Preclinical models for drug discovery for metastatic disease.
    L. Wakefield, S. Agarwal, Kandice Tanner · 2023 · Cell
  28. Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53
    Ruoji Zhou, An Xu, Julian A. Gingold, Louise C. Strong, Ruiying Zhao, Dung‐Fang Lee · 2017 · Trends in Pharmacological Sciences
  29. Patient-derived xenografts as preclinical neuroblastoma models
    Noémie Braekeveldt, Daniel Bexell · 2017 · Cell and Tissue Research
  30. Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools
    Muthu Dhandapani, Aaron J. Goldman · 2017 · Journal of Molecular Biomarkers & Diagnosis
  31. Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
    Hege Fredriksen Berg, Marta Espevold Hjelmeland, Hilde Eide Lien, Heidi Espedal, Tina Fonnes, Aashish Srivastava, Tomasz Stokowy, Elin Strand, Olivera Bozickovic, Ingunn M. Stefansson et al. · 2021 · Communications Medicine
  32. Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer
    Yan, Yuqian, An, Jian, Yang, Yinhui, Wu, Di, Bai, Yang, Cao, William, Ma, Linlin, Chen, Junhui, Yu, Zhendong, He, Yundong et al. · 2018 · EMBO Molecular Medicine
  33. Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research
    Mohamed Elbadawy, Amira Abugomaa, Hideyuki Yamawaki, Tatsuya Usui, Kazuaki Sasaki · 2020 · Cancers
  34. Curcumin and Andrographis Exhibit Anti-Tumor Effects in Colorectal Cancer via Activation of Ferroptosis and Dual Suppression of Glutathione Peroxidase-4 and Ferroptosis Suppressor Protein-1
    Katsuki Miyazaki, Caiming Xu, Mitsuo Shimada, Ajay Goel · 2023 · Pharmaceuticals
  35. A liquid biopsy for head and neck cancers
    Henri Schmidt, Arutha Kulasinghe, Chris Perry, Colleen C. Nelson, Chamindie Punyadeera · 2015 · Expert Review of Molecular Diagnostics
  36. Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology
    Patrick C. Bailey, Stuart S. Martin · 2019 · Cells
  37. Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
    Harri M. Itkonen, Ninu Poulose, Rebecca E. Steele, Sara E. S. Martin, Zebulon G. Levine, Damien Y. Duveau, Ryan Carelli, Reema Singh, Alfonso Urbanucci, Massimo F. Loda et al. · 2020 · Molecular Cancer Research
  38. Liver Organoids: Formation Strategies and Biomedical Applications
    Xinglong Zhu, Bingqi Zhang, Yuting He, Ji Bao · 2021 · Tissue Engineering and Regenerative Medicine
  39. Scalable Production and Cryostorage of Organoids Using Core–Shell Decoupled Hydrogel Capsules
    Lu, Yen‐Chun, Fu, Dah‐Jiun, An, Duo, Chiu, Alan, Schwartz, Robert, Nikitin, Alexander Yu., Ma, Minglin · 2017 · Advanced Biosystems
  40. Modeling human disease using organotypic cultures
    Pawel J. Schweiger, Kim Bak Jensen · 2016 · Current Opinion in Cell Biology
  41. Emerging Opportunities for Target Discovery in Rare Cancers
    Tanaz Sharifnia, Andrew Lee Hong, Corrie Painter, Jesse S. Boehm · 2017 · Cell chemical biology
  42. Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response
    Ayesha A. Shafi, Matthew Joseph Schiewer, Renée de Leeuw, Emanuela Dylgjeri, Peter A. McCue, Neelima Shah, Leonard G. Gomella, Costas D. Lallas, Edouard John Trabulsi, Margaret M. Centenera et al. · 2018 · European Urology Oncology
  43. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues
    Hirosumi Tamura, Arisa Higa, Hirotaka Hoshi, Gen Hiyama, Nobuhiko Takahashi, Masae Ryufuku, Gaku Morisawa, Yuka Yanagisawa, Emi Ito, Junichi Imai et al. · 2018 · Oncology Reports
  44. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade
    Yuji Sato, Jennifer K. Bolzenius, Abdallah M. Eteleeb, Xinming Su, Christopher A. Maher, Jennifer K. Sehn, Vivek K. Arora · 2018 · JCI Insight
  45. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer
    Rizzo, Giulia, Bertotti, Andrea, Leto, Simonetta Maria, Vetrano, Stefania · 2021 · Journal of Experimental & Clinical Cancer Research
  46. Circulating Tumor Cells: Overview and Opportunities in Cytology
    Kaitlin E. Sundling, Alarice Cheng-Yi Lowe · 2018 · Advances in Anatomic Pathology
  47. ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer
    Yaru Xu, Yuqiu Yang, Zhaoning Wang, Martin Sjöström, Yuyin Jiang, Yitao Tang, Siyuan Cheng, Su Deng, Choushi Wang, Julisa Gonzalez et al. · 2024 · Cancer Discovery
  48. Impact of label-free technologies in head and neck cancer circulating tumour cells
    Arutha Kulasinghe, Liz Kenny, Chris Perry, Jean Paul Thiery, Lidija Jovanovic, Ian Vela, Colleen C. Nelson, Chamindie Punyadeera · 2016 · Oncotarget
  49. Preclinical models for precision oncology
    Maider Ibarrola‐Villava, Andrès M.R. Cervantes, Alberto Bardelli · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  50. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors
    Wanlu Cao, Jiaye Liu, Ling Wang, Meng Li, Monique M. A. Verstegen, Yuebang Yin, Buyun Ma, Kan Chen, Michiel Bolkestein, Dave Sprengers et al. · 2018 · Carcinogenesis
  51. Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer research
    Romario Nguyen, Sarah Da Won Bae, Liang Qiao, Jacob George · 2021 · Cancer Letters
  52. The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation
    Arnold J. Levine, Anna M. Puzio‐Kuter, Chang S. Chan, Pierre L. Hainaut · 2016 · Cold Spring Harbor Perspectives in Medicine
  53. Papillary thyroid cancer organoids harboring BRAFV600E mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies
    Dong Chen, Xi Su, Lizhang Zhu, Jia Hao, Bin Han, Haibo Chen, Qingzhuang Liang, Chenchen Hu, Hao Yang, Lisa Liu et al. · 2023 · Journal of Translational Medicine
  54. AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification
    Hong Wang, Ji Liu, Xiaojun Zhu, Bin Yang, Zuping He, Xudong Yao · 2023 · Research
  55. CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
    Stella Baliou, Maria Adamaki, Anthony M. Kyriakopoulos, Demetrios A. Spandidos, Mihalis I. Panayiotidis, Ioannis Christodoulou, Vassilis C. Zoumpourlis · 2018 · International Journal of Oncology
  56. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
    Disharee Nath, Xiang Li, Claudia Mondragon, Dawn E. Post, Ming Chen, Julie R. White, Anita Hryniewicz‐Jankowska, Tiffany N. Caza, Vladimir A. Kuznetsov, Heidi Hehnly et al. · 2019 · Cell Communication and Signaling
  57. Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer
    Daniel Brungs, Elahe Minaei, Ann‐Katrin Piper, Jay R. Perry, Ashleigh Splitt, Martin Carolan, Shantay Ryan, Xiao Wu, Stéphanie Corde, Moeava Tehei et al. · 2020 · Scientific Reports
  58. Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
    Huixing Zhang, Dabao Xu, Yan Li, Jianqiang Lan, Yu Zhu, Jia Cao, Mingyue Hu, Juanjuan Yuan, Jin Peng He, Gang Li et al. · 2022 · International Journal of Biological Sciences
  59. Studying cancer metastasis: Existing models, challenges and future perspectives
    Denise M.S. van Marion, Urszula Domańska, Hetty Timmer‐Bosscha, Annemiek Walenkamp · 2015 · Critical Reviews in Oncology/Hematology
  60. Choosing wisely – Preclinical test models in the era of precision medicine
    Konrad Friedrich Klinghammer, Wolfgang Walther, Jens Hoffmann · 2017 · Cancer Treatment Reviews
  61. Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen
    Alex J. Walsh, Rebecca S. Cook, Melissa C. Skala · 2017 · Journal of Nuclear Medicine
  62. A Fast and Simple Fluorometric Method to Detect Cell Death in 3D Intestinal Organoids
    Konstantin J. Bode, Stefanie Mueller, Matthias Schweinlin, Marco Metzger, Thomas Brunner · 2019 · BioTechniques
  63. Organoid culture system for patient-derived lung metastatic osteosarcoma
    Aina He, Yujing Huang, Wanying Cheng, Deng Zhang, Weiwei He, Yueqing Bai, Chao Gu, Zhongping Ma, Zhenfang He, Guifan Si et al. · 2020 · Medical Oncology
  64. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
    Anmi Jose, Pallavi Kulkarni, Jaya Thilakan, Murali Munisamy, Anvita Gupta Malhotra, Jitendra Singh, Ashok Kumar, Vivek M. Rangnekar, Neha Arya, Mahadev Rao · 2024 · Molecular Cancer
  65. Leveraging 3D cell culture and AI technologies for next-generation drug discovery
    Raj Dave, Kshipra Pandey, Ritu Bhaumik Patel, Nidhi Gour, Dhiraj Devidas Bhatia · 2025 · Cell Biomaterials
  66. 3D Miniaturization of Human Organs for Drug Discovery
    Joseph Park, Isaac Wetzel, Didier Dréau, Hansang Cho · 2017 · Advanced Healthcare Materials
  67. A New Era of Prostate Cancer Precision Medicine
    Adil Malik, Srilakshmi Srinivasan, Jyotsna Batra · 2019 · Frontiers in Oncology
  68. Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine
    Pierre‐Olivier Frappart, Thomas G. Hofmann · 2020 · Cancers
  69. Microfluidic techniques for isolation, formation, and characterization of circulating tumor cells and clusters
    Celine Macaraniag, Qiyue Luan, Jian Zhou, Ian Papautsky · 2022 · APL Bioengineering
  70. Living biobank-based cancer organoids: prospects and challenges in cancer research
    Haixin Li, Hongkun Liu, Kexin Chen · 2022 · Cancer Biology and Medicine
  71. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products
    André Franken, Christiane Driemel, Bianca Behrens, Franziska Meier-Stiegen, Volker Endris, Albrecht Stenzinger, Dieter Niederacher, Johannes Fischer, Nikolas Hendrik Stoecklein, Eugen Ruckhaeberle et al. · 2019 · Clinical Chemistry
  72. Establishing Pure Cancer Organoid Cultures: Identification, Selection and Verification of Cancer Phenotypes and Genotypes
    Nina Wallaschek, Carolin Niklas, Malvika Pompaiah, Armin Wiegering, Christoph‐Thomas Germer, Stefan Kircher, Stephanie Brändlein, Katja Maurus, Andreas Rosenwald, Helen H.N. Yan et al. · 2019 · Journal of Molecular Biology
  73. Therapeutic applications of PARP inhibitors in ovarian cancer
    Hongyu Xie, Wenjie Wang, Bairong Xia, Weilin Jin, Ge Lou · 2020 · Biomedicine & Pharmacotherapy
  74. ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming
    Fei Li, Qiuyue Yuan, Wei Di, Xinyi Xia, Zhuang Liu, Ninghui Mao, Lin Li, Chunfeng Li, Juan He, Yunguang Li et al. · 2020 · Journal of Clinical Investigation
  75. An update of label-free protein target identification methods for natural active products
    Zhao Cui, Caifeng Li, Peng Chen, Hongjun Yang · 2022 · Theranostics
  76. A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
    Stacey Price, Shriram G. Bhosle, Emanuel Gonçalves, Xiaodun Li, Dylan Peter McClurg, Syd Barthorpe, Alexandra Beck, Caitlin Hall, Howard W. Lightfoot, Luke Farrow et al. · 2022 · Scientific Reports
  77. Flourishing tumor organoids: History, emerging technology, and application
    Qian Yang, Mengmeng Li, Xinming Yang, Zian Xiao, Xinying Tong, Ayinuer Tuerdi, Shisheng Li, Lanjie Lei · 2023 · Bioengineering & Translational Medicine
  78. Organoids as Innovative Models for Bone and Joint Diseases
    Jie Huang, Lingqiang Zhang, Aiping Lü, Chao Liang · 2023 · Cells
  79. Engineered biomimetic hydrogels for organoids
    Yihan Li, Qimanguli Saiding, Zhen Wang, Wenguo Cui · 2023 · Progress in Materials Science
  80. Recent advances in the biology of human circulating tumour cells and metastasis
    Sofia Gkountela, Barbara Maria Szczerba, Cinzia Donato, Nicola Aceto · 2016 · ESMO Open
  81. Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer
    Hong Pan, Keith H. Jansson, Michael L. Beshiri, JuanJuan Yin, Lei Fang, Supreet Agarwal, Holly M. Nguyen, Eva Corey, Ying Zhang, Jie Liu et al. · 2017 · Oncotarget
  82. Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
    Sung Yong Choi, A-Ra Jeon, Min Kyeong Kim, Yu‐Sun Lee, Ji-Eun Im, Jung-Wook Koh, Sung‐Sik Han, Sun‐Young Kong, Kyong‐Ah Yoon, Young Hwan Koh et al. · 2019 · Frontiers in Oncology
  83. Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease
    Petr Pleskač, Christine A. Fargeas, Renata Veselská, Denis Corbeil, Jan Skoda · 2024 · Cellular & Molecular Biology Letters
  84. Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer
    Saba Choudhary, Poornema Ramasundaram, Eugenia Dziopa, Ciaran M. Mannion, Yair Kissin, Lucas Tricoli, Christopher Albanese, Woo Lee, Jenny Zilberberg · 2018 · Scientific Reports
  85. Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer
    Joanna Kapeleris, Arutha Kulasinghe, Majid Ebrahimi Warkiani, Connor Gerard O’Leary, Ian Vela, Paul Leo, Peter R. Sternes, Kenneth John O'Byrne, Chamindie Punyadeera · 2020 · Translational Lung Cancer Research
  86. Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
    Norman J. Maitland · 2021 · Cancers
  87. Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications
    Nuria Carmona-Ule, Miriam González-Conde, Carmen Abuín, Juan Fernando Cueva, Patricia Palacios, Rafael López‐López, Clotilde Costa, Ana Belén Dávila-Ibáñez · 2021 · Cancers
  88. Functional 3-Dimensional Retinal Organoids: Technological Progress and Existing Challenges
    Meimanat Fathi, Cody T. Ross, Zohreh Hosseinzadeh · 2021 · Frontiers in Neuroscience
  89. Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology
    Maria Concetta Scuto, Angela Trovato Salinaro, Isabella Caligiuri, Maria Laura Ontario, Valentina Greco, Nello Sciuto, Roberto Crea, Edward J. Calabrese, Flavio Rizzolio, Vincenzo Canzonieri et al. · 2021 · Mechanisms of Ageing and Development
  90. Gastric Organoids: Progress and Remaining Challenges
    Min-Jiao Pang, Joseph Burclaff, Ramon U. Jin, Mahliyah Adkins-Threats, Luciana H. Osaki, Yunan Han, Jason C. Mills, Zhi‐Feng Miao, Zhen-Ning Wang · 2021 · Cellular and Molecular Gastroenterology and Hepatology
  91. Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
    Lucas Germain, Camille Lafront, Virginie Paquette, Bertrand Neveu, Jean‐Sébastien Paquette, Frédéric Pouliot, Étienne Audet‐Walsh · 2023 · Nature Reviews Urology
  92. Organotypic three-dimensional cancer cell cultures mirror drug responses<i>in vivo</i>: lessons learned from the inhibition of EGFR signaling
    Jacobi, Nico, Seeboeck, Rita, Hofmann, Elisabeth, Schweiger, Helmut, Smolinska, Veronika, Mohr, Thomas, Boyer, Alexandra, Sommergruber, Wolfgang, Lechner, Peter, Pichler-Huebschmann, Corina et al. · 2017 · Oncotarget
  93. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects
    Sander B. Frank, Peter S. Nelson, Valeri I. Vasioukhin · 2018 · F1000Research
  94. Models for Understanding Resistance to Chemotherapy in Liver Cancer
    José J.G. Marı́n, Elisa Herráez, Elisa Lozano, Rocı́o I.R. Macı́as, Óscar Briz · 2019 · Cancers
  95. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours
    Pina Fusco, B. Parisatto, Elena Rampazzo, Luca Persano, Chiara Frasson, Annamaria Di Meglio, A Leslz, L. Santoro, Barbara Cafferata, Angelica Zin et al. · 2019 · BMC Cancer
  96. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
    Singh, Kamini, Lin, Jianan, Lecomte, Nicolas, Mohan, Prathibha, Gokce, Askan, Sanghvi, Viraj R., Jiang, Man, Grbovic-Huezo, Olivera, Burčul, Antonija, Stark, Stefan G. et al. · 2021 · Cancer Research
  97. Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
    Hélène Lasolle, Andréa Alex Schiavo, Adrien Tourneur, Pierre Gillotay, Bárbara F. Fonseca, Lucieli Ceolin, Olivier Monestier, Benilda Aganahi, Laura Chomette, Marina M. L. Kizys et al. · 2023 · Oncogene
  98. The viable circulating tumor cells with cancer stem cells feature, where is the way out?
    Yang Luo, Jin Quan Cheng, X. Feng, Songbing He, Yawei Wang, Q. Huang · 2018 · Journal of Experimental & Clinical Cancer Research
  99. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening
    Jie Li, Huawei Xu, Lixing Zhang, Lele Song, Dan Feng, Xiaobo Peng, Meihong Wu, Yang Zou, Bin Wang, Lixing Zhan et al. · 2019 · Journal of Cancer Research and Clinical Oncology
  100. Microfluidics for personalized drug screening of cancer
    Nishanth Venugopal Menon, Su Bin Lim, Chwee Teck Lim · 2019 · Current Opinion in Pharmacology